Old Web
English
Sign In
Acemap
>
authorDetail
>
P. Meizlik
P. Meizlik
Medicine
Immunology
Eosinophilic asthma
Internal medicine
Reslizumab
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
POS0696 SAFETY AND EFFICACY OF BELIMUMAB IN OLDER ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF AN INTEGRATED ANALYSIS
2021
Annals of the Rheumatic Diseases
D D’Cruz
G. Eriksson
Y. Green
Anne E. Hammer
Beulah Ji
P. Meizlik
David M. Roth
Show All
Source
Cite
Save
Citations (0)
POS0697 SAFETY OF BELIMUMAB IN ADULT PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A LARGE INTEGRATED SAFETY ANALYSIS OF CONTROLLED CLINICAL TRIAL DATA
2021
Annals of the Rheumatic Diseases
Daniel J. Wallace
T. Atsumi
M. Daniels
Anne E. Hammer
P. Meizlik
H. Quasny
Andreas Schwarting
F. Zhang
David M. Roth
Show All
Source
Cite
Save
Citations (0)
P223 Reslizumab improves spirometric lung age in patients with severe eosinophilic asthma
2017
Annals of Allergy Asthma & Immunology
Warner W. Carr
Mirna McDonald
P. Meizlik
Show All
Source
Cite
Save
Citations (0)
1
map